Unknown

Dataset Information

0

Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis.


ABSTRACT:

Background

The prognostic value of preoperative fluorine-18-fluorodeoxyglucose positron-emission tomography (18F-FDG PET) scan for determining overall survival (OS) in breast cancer (BC) patients is controversial.

Aim

To evaluate the OS predictive value of preoperative PET positivity after 15 years.

Methods

We performed a retrospective search of the Universitair Ziekenhuis Brussel patient database for nonmetastatic patients who underwent preoperative PET between 2002-2008. PET positivity was determined by anatomical region of interest (AROI) findings for breast and axillary, sternal, and distant sites. The prognostic role of PET was examined as a qualitative binary factor (positive vs negative status) and as a continuous variable [maximum standard uptake value (SUVmax)] in multivariate survival analyses using Cox proportional hazards models. Among the 104 identified patients who received PET, 36 were further analyzed for the SUVmax in the AROI.

Results

Poor OS within the 15-year study period was predicted by PET-positive status for axillary (P = 0.033), sternal (P = 0.033), and combined PET-axillary/sternal (P = 0.008) nodes. Poor disease-free survival was associated with PET-positive axillary status (P = 0.040) and combined axillary/sternal status (P = 0.023). Cox models confirmed the long-term prognostic value of combined PET-axillary/sternal status [hazard ratio (HR): 3.08, 95% confidence interval: 1.42-6.69]. SUVmax of ipsilateral breast and axilla as continuous covariates were significant predictors of long-term OS with HRs of 1.25 (P = 0.048) and 1.54 (P = 0.029), corresponding to relative increase in the risk of death of 25% and 54% per SUVmax unit, respectively. In addition, the ratio of the ipsilateral axillary SUVmax over the contralateral axillary SUVmax was the most significant OS predictor (P = 0.027), with 1.94 HR, indicating a two-fold relative increase of mortality risk.

Conclusion

Preoperative PET is valuable for prediction of long-term survival. Ipsilateral axillary SUVmax ratio over the uninvolved side represents a new prognostic finding that warrants further investigation.

SUBMITTER: Perrin J 

PROVIDER: S-EPMC9052070 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Is there utility for fluorine-18-fluorodeoxyglucose positron-emission tomography scan before surgery in breast cancer? A 15-year overall survival analysis.

Perrin Justine J   Farid Karim K   Van Parijs Hilde H   Gorobets Olena O   Vinh-Hung Vincent V   Nguyen Nam P NP   Djassemi Navid N   De Ridder Mark M   Everaert Hendrik H  

World journal of clinical oncology 20220401 4


<h4>Background</h4>The prognostic value of preoperative fluorine-18-fluorodeoxyglucose positron-emission tomography (<sup>18</sup>F-FDG PET) scan for determining overall survival (OS) in breast cancer (BC) patients is controversial.<h4>Aim</h4>To evaluate the OS predictive value of preoperative PET positivity after 15 years.<h4>Methods</h4>We performed a retrospective search of the Universitair Ziekenhuis Brussel patient database for nonmetastatic patients who underwent preoperative PET between  ...[more]

Similar Datasets

| S-EPMC2992843 | biostudies-literature
| S-EPMC6884607 | biostudies-literature
| S-EPMC9830889 | biostudies-literature
| S-EPMC7403810 | biostudies-literature
| S-EPMC11891561 | biostudies-literature
| S-EPMC4839768 | biostudies-literature
| S-EPMC10232332 | biostudies-literature
| S-EPMC7711422 | biostudies-literature